Center Leadership
Alan Budney, PhD
Alan Budney, PhD
Director, Treatment Development & Evaluation Core
Alan Budney is a Professor at the Geisel School of Medicine at Dartmouth. He received his PhD in Clinical Psychology from Rutgers University and did his postdoctoral training at the University of Vermont. He is Director of the Treatment Development & Evaluation Core of Dartmouth’s Center for Technology and Behavioral Health and also directs a NIDA-funded T32 training program on the Science of Co-Occurring Disorders. He has conducted extensive research on the development and evaluation of innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents. This programmatic research has focused on integrating innovative contingency management interventions with more traditional behavioral therapies and using computer-assisted therapies to enhance access to and the cost effectiveness of these approaches. He has also conducted human laboratory and survey studies characterizing cannabis use and withdrawal. His recent work leverages social media recruitment strategies to assess the impact of the changing legal landscape of cannabis and to develop on-line interventions for cannabis use problems. Dr. Budney was President of Division 28 and Division 50 of the American Psychological Association and the College on Problems of Drug Dependence. He was a member of the DSM-5 Substance Use Disorders working group and has served on numerous scientific reviews at the NIH and other institutions. He is currently on the Scientific Advisory Board of the Center for Medical Cannabis Research at the University of California San Diego. Dr. Budney has also been an active member of many community task forces targeting reduction in delinquency, violence, and substance use problems.
Dr. Budney is an avid sports fan and enjoys the theatre. He will play golf with anyone interested whenever possible, enjoys downhill skiing when not injured, and would love to BBQ if you’d like to stop by his home in Hanover, NH.
Selected Publications
- Budney AJ, Sofis MJ, Borodovsky JT. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci. 2019 Jan 2. doi: 10.1007/s00406-018-0976-1. PMID: 30604051. View Source
- Lee DC, Walker DD, Hughes JR, Brunette MF, Scherer E, Stanger C, Etter JF, Auty S, Budney AJ. Sequential and simultaneous treatment approaches to cannabis use disorder and tobacco use. J Subst Abuse Treat. 2019 Mar;98:39-46. doi:10.1016/j.jsat.2018.12.005. PMID: 30665602. View Source
- Knapp AA, Lee DC, Borodovsky JT, Auty SG, Gabrielli JL, Budney AJ. Emerging trends in cannabis administration among adolescent cannabis users. J Adolesc Health. 2018 Sep 8. doi: 10.1016/j.jadohealth.2018.07.012. PMID:30205931 View Source
- Borodovsky JT, Budney AJ. Cannabis regulatory science: Risk-benefit considerations for mental disorders. Int Rev Psychiatry. 2018 May 29:1-20. doi: 10.1080/09540261.2018.1454406. PMID: 29843548 View Source
- Borodovsky JT, Marsch LA, Budney AJ. Studying cannabis use behaviors with Facebook and web surveys: Methods and insights. JMIR Public Health Surveill. 2018 May 2;4(2):e48. doi: 10.2196/publichealth.9408. PMID: 29720366. View Source
- Budney AJ, Borodovsky JT. The potential impact of cannabis legalization on the development of cannabis use disorders. Preventive Medicine. 2017;104:31-6. PMCID:PMC5735001. View Source
- Stanger C, Scherer EA, Babbin SF, Ryan SR, Budney AJ. Abstinence based incentives plus parent training for adolescent alcohol and other substance misuse. Psychology of Addictive Behaviors. 2017. doi: 10.1037/adb0000279. PMID:28414474. View Source
- Borodovsky JT, Crosier BS, Lee DC, Sargent JD, Budney AJ. Smoking, vaping, eating: Is legalization impacting the way people use cannabis? The International Journal on Drug Policy. 2016. PMID:26992484. View Source
- Stanger C, Lansing AH, Budney AJ. Advances in research on contingency management for adolescent substance use. Child Adolesc Psychiatr Clin N Am. 2016 Oct;25(4):645-59. doi: 10.1016/j.chc.2016.05.002. PMID: 27613343; PMCID: PMC5019116. View Source
- Babbin SF, Stanger C, Scherer EA, Budney AJ. Identifying treatment response subgroups for adolescent cannabis use. Addictive Behaviors. 2016;59:72-79. PMCID: PMC4846516. View Source
- Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction. 2015. PMID:26264448. View Source
- Budney AJ, Stanger C, Tilford JM, Scherer EB, Brown PC, Li Z, Li Z, Walker DD. Computer-assisted behavioral therapy and contingency management for cannabis use disorder. Psychol Addict Behav. 2015 Sep;29(3):501-11. doi: 10.1037/adb0000078. PMID: 25938629; PMCID: PMC4586287. View Source
- Stanger C, Ryan SR, Scherer EA, Norton GE, Budney AJ. Clinic- and home-based contingency management plus parent training for adolescent cannabis use disorders. Journal of the American Academy of Child & Adolescent Psychiatry.54(6):445-453.e442. DOI: http://dx.doi.org/10.1016/j.jaac.2015.02.009. View Source
- Stanger C, Budney AJ, Bickel WK. A developmental perspective on neuroeconomic mechanisms of contingency management. Psychology of Addictive Behaviors. 2013 Jun;27(2):403-15. PMID: 22663343; PMCID: PMC3443497. View Source
- Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. Journal of Substance Abuse Treatment. 2008 Dec;35(4):362-8. PMID: 18342479. View Source
- Budney AJ, Moore BA, Rocha HL, Higgins ST. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. Journal of Consulting and Clinical Psychology. 2006 Apr;74(2):307-16. PMID: 16649875. View Source
- Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry. 2004 Nov;161(11):1967-77. PubMed PMID: 15514394. View Source